Copyright
©The Author(s) 2025.
World J Gastroenterol. Jan 28, 2025; 31(4): 101933
Published online Jan 28, 2025. doi: 10.3748/wjg.v31.i4.101933
Published online Jan 28, 2025. doi: 10.3748/wjg.v31.i4.101933
No. | Possible consequences of long-term use of proton pump inhibitors |
1 | Significant deficiency of vitamins (B12 and C) and minerals (iron, calcium and magnesium) |
2 | Potential risk of congenital malformations in pregnant women |
3 | Infections of the intestine including Clostridium difficile, respiratory and urinary tract |
4 | Hypergastrinemia, which ultimately mediates the development of gastric polyps, gastric carcinoids and gastric cancer |
5 | Concomitant use of proton pump inhibitors with antiplatelet drugs such as clopidogrel may cause serious adverse cardiac events in patients |
6 | Osteoporosis-related fractures |
7 | Dementia |
8 | Rebound effect, hypersecretion after proton pump inhibitor withdrawal |
9 | Atrophy of the gastric mucosa (glands) |
- Citation: Kotelevets SM. Risks of anti-Helicobacter therapy and long-term therapy with antisecretory drugs. World J Gastroenterol 2025; 31(4): 101933
- URL: https://www.wjgnet.com/1007-9327/full/v31/i4/101933.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i4.101933